These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 35872297)

  • 1. Pleiotropic properties of statins via angiogenesis modulation in cardiovascular disease.
    Zahedipour F; Butler AE; Eid AH; Sahebkar A
    Drug Discov Today; 2022 Oct; 27(10):103325. PubMed ID: 35872297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins and angiogenesis in non-cardiovascular diseases.
    Zahedipour F; Butler AE; Rizzo M; Sahebkar A
    Drug Discov Today; 2022 Oct; 27(10):103320. PubMed ID: 35850434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse effects of statins on angiogenesis: new therapeutic avenues.
    Elewa HF; El-Remessy AB; Somanath PR; Fagan SC
    Pharmacotherapy; 2010 Feb; 30(2):169-76. PubMed ID: 20099991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results.
    Wang CY; Liu PY; Liao JK
    Trends Mol Med; 2008 Jan; 14(1):37-44. PubMed ID: 18068482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins have biphasic effects on angiogenesis.
    Weis M; Heeschen C; Glassford AJ; Cooke JP
    Circulation; 2002 Feb; 105(6):739-45. PubMed ID: 11839631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic effects of HMG-CoA reductase inhibitors.
    Bocan TM
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy.
    Zhou Q; Liao JK
    Curr Pharm Des; 2009; 15(5):467-78. PubMed ID: 19199975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HMG-CoA reductase pathway, statins and angioprevention.
    Feng C; Han A; Ye C; Xu R; Li M
    Semin Ophthalmol; 2006; 21(1):29-35. PubMed ID: 16517442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?
    Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin therapy and angiogenesis.
    Skaletz-Rorowski A; Walsh K
    Curr Opin Lipidol; 2003 Dec; 14(6):599-603. PubMed ID: 14624137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin therapy in cardiovascular diseases other than atherosclerosis.
    Beaudry D; Stone KE; Wetherold S; Hemphill J; Do D; McClish J; Chilton R
    Curr Atheroscler Rep; 2007 Jan; 9(1):25-32. PubMed ID: 17228487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleiotropic Benefits of Statins in Cardiovascular Diseases.
    Wasim R; Ansari TM; Ahsan F; Siddiqui MH; Singh A; Shariq M; Parveen S
    Drug Res (Stuttg); 2022 Nov; 72(9):477-486. PubMed ID: 35868336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleiotropic effects of statins: A focus on cancer.
    Ahmadi M; Amiri S; Pecic S; Machaj F; Rosik J; Łos MJ; Alizadeh J; Mahdian R; da Silva Rosa SC; Schaafsma D; Shojaei S; Madrakian T; Zeki AA; Ghavami S
    Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165968. PubMed ID: 32927022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of statins on toll-like receptors: a new insight to pleiotropic effects.
    Bahrami A; Parsamanesh N; Atkin SL; Banach M; Sahebkar A
    Pharmacol Res; 2018 Sep; 135():230-238. PubMed ID: 30120976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR; Kanwar YS
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.
    Yeganeh B; Wiechec E; Ande SR; Sharma P; Moghadam AR; Post M; Freed DH; Hashemi M; Shojaei S; Zeki AA; Ghavami S
    Pharmacol Ther; 2014 Jul; 143(1):87-110. PubMed ID: 24582968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of statin therapy on the progression of chronic kidney disease.
    Shah S; Paparello J; Danesh FR
    Adv Chronic Kidney Dis; 2005 Apr; 12(2):187-95. PubMed ID: 15822054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins: potential new indications in inflammatory conditions.
    Endres M
    Atheroscler Suppl; 2006 Apr; 7(1):31-5. PubMed ID: 16503422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.